The Australian Therapeutic Goods Administration (TGA) has granted approval for Novartis' multi-component Meningococcal B (MenB) vaccine, Bexsero, for use against a dangerous form of bacterial meningitis, MenB disease. The approval will ...
Tags: Menb Disease, Medicine
Bexsero, Novartis' Meningococcal Group B Vaccine, has won a positive opinion from European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP). The CHMP opinion indicates the use of the broad coverage vaccine in ...